(Q38779665)

6 September 2017

Long-term efficacy of adalimumab in the treatment of uveitis associated with juvenile idiopathic arthritis (English)

1 reference

juvenile rheumatoid arthritis

6 September 2017

0 references

1 reference

1 reference

3

Hannu Kautiainen

1 reference

6 September 2017

Kaisu Kotaniemi

1

1 reference

6 September 2017

Hanna Säilä

series ordinal

2

1 reference

6 September 2017

language of work or name

English

0 references

publication date

3 October 2011

1 reference

6 September 2017

Clinical Ophthalmology

1 reference

6 September 2017

5

1 reference

6 September 2017

1425-1429

1 reference

Creative Commons Attribution-NonCommercial 3.0 Unported

6 September 2017

start time

1 October 2011

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Adalimumab in the therapy of uveitis in childhood

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3198418

Tumour necrosis factor alpha inhibitors in the treatment of childhood uveitis.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3198418

Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3198418

Decreased incidence of anterior uveitis in patients with ankylosing spondylitis treated with the anti-tumor necrosis factor agents infliximab and etanercept

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3198418

Biologic agents for the treatment of juvenile rheumatoid arthritis: current status

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3198418

International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3198418

Recent advances in uveitis of juvenile idiopathic arthritis

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3198418

Juvenile arthritis and uveitis

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3198418

Preliminary criteria for clinical remission for select categories of juvenile idiopathic arthritis.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3198418

Adalimumab in juvenile idiopathic arthritis-associated chronic anterior uveitis.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3198418

Tumor necrosis factor-alpha blocker in treatment of juvenile idiopathic arthritis-associated uveitis refractory to second-line agents: results of a multinational survey.

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3198418

Safety and efficacy of adalimumab treatment in Greek children with juvenile idiopathic arthritis

31 August 2018

1 reference

12 December 2020

Adalimumab therapy for childhood uveitis

1 reference

12 December 2020

Aqueous Humor and Serum Tumor Necrosis Factor-α in Clinical Uveitis

1 reference

12 December 2020

Differential efficacy of tumor necrosis factor inhibition in the management of inflammatory eye disease and associated rheumatic disease

1 reference

12 December 2020

Extended oligoarthritis and other risk factors for developing JIA-associated uveitis under ILAR classification and its implication for current screening guideline

1 reference

12 December 2020

Identifiers

DOI

10.2147/OPTH.S23646

1 reference

6 September 2017

1 reference

6 September 2017

PubMed publication ID

22034564

1 reference